What is the current stock price of JCR Pharmaceuticals Co., Ltd. (JCRRF)?

As of the latest market data, JCR Pharmaceuticals Co., Ltd. (JCRRF) is trading at $4.17. The stock has seen a loss of 0.00% today.

Does JCR Pharmaceuticals Co., Ltd. (JCRRF) pay a dividend?

Based on current data, JCR Pharmaceuticals Co., Ltd. does not have a confirmed active dividend policy.

What is the market cap of JCR Pharmaceuticals Co., Ltd.?

The current market capitalization of JCR Pharmaceuticals Co., Ltd. (JCRRF) is approximately unavailable.

JCRRF

JCR Pharmaceuticals Co., Ltd.·Healthcare

4.17

0.000%(+0.00)

Close Price

Last Updated: — ET

52W L: $3.7852W H: $5.00

JCRRF NEWS

businesswire.com

May 18

JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising Central Nervous System Uptake at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

HYOGO, Japan--(BUSINESS WIRE)--JCR announced today that it presented preclinical data from its novel platform technologies in oral and poster sessions at the ASGCT Annual Meeting.

businesswire.com

May 11

JCR Pharmaceuticals to Present at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

HYOGO, Japan--(BUSINESS WIRE)--JCR will present preclinical data from its novel platform technologies, including JUST-AAV gene therapy, at the ASGCT 29th Annual Meeting this week.

Company Profile

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

934

IPO Date

2021-01-29

Beta

0.17

Websitewww.jcrpharm.co.jp↗